The PAR2 Antagonist Larazotide Can Mitigate Acute Histamine-Stimulated Epithelial Barrier Disruption in Keratinocytes: A Potential Adjunct Treatment for Atopic Dermatitis
Atopic dermatitis (AD) is a chronic inflammatory skin condition with evidence of defects in the barrier properties of the epidermis. Changes in the permeability properties of the tight junction have been reported in AD, and reversing this leaky tight junction may be a potential treatment for AD. Thi...
Saved in:
| Main Authors: | Danielle M. Glinka, Gordon G. MacGregor |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | JID Innovations |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667026725000256 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transcriptomics insights into glutamine on repairing of histamine-induced Yak rumen epithelial cells barrier damage in vitro
by: Xiaohong Zhang, et al.
Published: (2025-02-01) -
Mechanism of intestinal tight junction transmembrane proteins interaction with egg white peptides RVPSL and QIGLF
by: Zhipeng Yu, et al.
Published: (2025-09-01) -
HISTAMIN RELEASE FROM INTESTINAL MICROBIOTA IN CHILDREN WITH ATOPIC DERMATITIS
by: S. Yu. Nosyreva, et al.
Published: (2016-09-01) -
Glucose ingestion increases passive absorption of a nutrient‐sized solute, mannitol, in healthy young adults
by: G. Patrick Lambert, et al.
Published: (2025-06-01) -
Retinol and Hydroxyasiaticoside Synergistically Relieve Histamine-Induced Atopic Dermatitis Activity by Repressing TRPV1, L1R1, and CD130 Targets
by: Qin Liu, et al.
Published: (2024-11-01)